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 2 
ABSTRACT 10 
Quality of life (QoL) plays a significant role in the treatment of dogs with idiopathic epilepsy 11 
(IE) yet is so far understudied. This study describes the outcome evaluation of an online 12 
questionnaire based on the carer’s perception focusing on 62 QoL-questions in 159 dogs with 13 
IE.  14 
Results showed that seizure frequency, but not seizure severity or presence of cluster seizures 15 
was significantly associated with carer perceived dog’s QoL. Dogs receiving third line 16 
antiepileptic drugs had a significantly lower perceived QoL than those that did not. 17 
Generalised linear mixed model analysis demonstrated that severity of the side effects 18 
sleeping more and ataxia were significantly associated with carer perceived dog’s QoL, with 19 
higher severities predicting lower QoL scores. The degree of carer acceptability of seizure 20 
frequency and severity was significantly associated with the dog’s reported seizure frequency 21 
and severity. Moreover, there was a significant association between IE-related QoL changes 22 
of the dog and the carer, with reductions in perceived canine QoL scores associated with 23 
reductions in carer QoL, and vice versa.  24 
In conclusion, aspects of canine IE can affect both the carer and their dog’s QoL. This has 25 
implications for the management and requires consideration when treatment options and 26 
outcomes are discussed. 27 
 28 
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INTRODUCTION 32 
Canine epilepsy studies mainly focus on the physical aspects of seizures, the impact of 33 
antiepileptic drugs (AED) and more recently also behavioural changes associated with the 34 
disease (Lord and Podell 1999, Chang and others 2006, Shihab and others 2011, Muñana and 35 
others 2012). The physical aspects of canine idiopathic epilepsy (IE) such as seizure 36 
frequency and severity as well as AED side effects are well described, yet the suspected 37 
impact on QoL has only been studied in small numbers of affected dogs. Carers of 37 dogs 38 
with IE were mostly concerned about the dog’s QoL, adequate seizure frequency (less than 39 
one seizure every three months) and acceptable side effects of AEDs and that these factors 40 
would determine if seizure control was adequate (Chang and others 2006).  41 
 42 
Neurobehavioral changes are a reported comorbidity of epilepsy in dogs and humans and 43 
include cognitive, behavioural or emotional changes associated with central nervous system 44 
dysfunction. These comorbidities in dogs include increased fear/anxiety, defensive 45 
aggression, abnormal perception, inattention, excitability/impulsivity, and show remarkable 46 
similarities to its human counterpart resembling anxiety and attention deficit hyperactivity 47 
disorder (Shihab and others 2011, Jokinen and others 2015, Packer and others 2016). The 48 
carer commonly assesses non-metric aspects like neurobehavioral changes and QoL aspects 49 
based on their perception (Lord and Podell 1999, Chang and others 2006, Shihab and others 50 
2011, Muñana and others 2012, Packer and others 2016). The carer’s perception of their dog’s 51 
QoL may be biased but with this in mind the carer can serve as surrogate. This is an accepted 52 
practice not only in veterinary medicine but also in childhood epilepsy where usually the 53 
parent assesses the QoL of the epileptic child (Liu and Han 2015). It is further known that not 54 
only the QoL of the affected child but also of their carer can be affected in childhood 55 
epilepsy. Parents of epileptic children showed significantly lower QoL scores, and higher 56 
 4 
levels of depression and anxiety correlating to seizure control, employment, financial 57 
implications of caring for an individual with epilepsy, the occurrence of status epilepticus, 58 
drug side effects and age of parents among others (Lv and others 2009). Information about the 59 
impact of caring for an epileptic dog on the carer’s QoL is limited yet effect on the carer’s 60 
day-to-day activities and their free time are describes (Lord and Podell 1999, Chang and 61 
others 2006).  62 
 63 
Wessmann et al. (2014) published the creation of a disease-specific QoL questionnaire in 64 
dogs with IE and their carers (EpiQoL). The questionnaire design was based on the 65 
multidimensional aspects of QoL as defined by the WHO into physical, social, and 66 
neurobehavioral (dog) / psychological health aspects (carer) adapted for IE (Wessmann and 67 
others 2014). The current study explores the actual data and factors that affect QoL in dogs 68 
with IE and their carers with seven hypotheses (H1-H7) utilising data from Wessmann and 69 
others (2014). The QoL measures in this study largely focused on the carer’s perception of 70 
their dog’s and their own QoL. 71 
 72 
H1: The seizure phenotype (frequency of seizure days, severity) affects the carer’s perception 73 
of QoL in canine IE patients.  74 
H2: There is an effect of being treated with certain AEDs upon carer perception of canine 75 
epilepsy.  76 
H3: Side effects of AEDs impact upon carer perception of canine QoL.  77 
H4: The reported severities of AED side effects are associated with the degree of carer 78 
acceptability of AED side effects.   79 
H5: A dog’s seizure frequency is associated with the degree of carer acceptability of seizure 80 
frequency.  81 
 5 
H6: A dog’s seizure severity is associated with the degree of carer acceptability of seizure 82 
severity.   83 
H7: There is an association between changes in carer QoL and carer perception of their dog’s 84 
QoL following the onset of IE.  85 
 86 
MATERIAL AND METHODS 87 
Carers of dogs diagnosed with IE were recruited at the authors’ institutions (UGVS, RVC) by 88 
paper mail stating a link to the online questionnaire, through contacting 800 primary care 89 
practices by email and though a canine epilepsy website (www.canineepilepsy.co.uk). Data 90 
was acquired from January to November 2011. Dogs were included if they presented with 91 
recurrent seizures (two or more) at least one month apart which were either presumptively 92 
diagnosed with IE following substantial investigation, including normal brain imaging (MRI 93 
or CT) and cerebrospinal fluid analysis independent of the age of onset or strongly suspected 94 
to have IE with seizures for more than one year and an age of onset between 6 months to 6 95 
years. Responses were excluded if other diseases that required ongoing veterinary treatment 96 
or attention were reported or if the dog was not alive at the time of completion of the 97 
questionnaire (Wessmann and others 2014). 98 
This study reports the outcome of 36 key questions (EpiQoL) associated with IE in 159 99 
affected dogs and their carer’s, as previously described by the authors (Supplementary file A, 100 
Wessmann and others 2014). Items such as seizure severity, frequency and side effects of 101 
AEDs were considered to affect the physical aspects of the dog. The seizure frequency 102 
considered the ‘seizure days’ on which seizures occurred and therefore could include single 103 
and multiple seizures (‘cluster’) for this day. Items such as restrictions and frustrations on the 104 
carer’s life such as limitations in work, education, day-to-day activities, and social life 105 
because of caring for an epileptic dog were grouped under the social aspects affecting the 106 
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carer. Psychological health aspects affecting the carer included items such as the carer’s 107 
distaste of AED side effects and carer anxiety around the seizure frequency and severity and 108 
its effects on the dog (Supplementary file A). Twenty-six additional questionnaire items from 109 
the original project questionnaire were included such as direct QoL focused questions, 110 
descriptive data around the seizure event, psychological health aspects of the carer concerning 111 
mainly the dog’s health and the effect on the carer (Supplementary file B). A total of 62 112 
questions were used to test the aforementioned hypotheses.  113 
 114 
Statistical analysis 115 
To investigate the above seven questions, three carer-reported proxies of canine QoL were 116 
used as outcome measures:  117 
(i) A score from 1-10 (treated as continuous, with 1 being the worst and 10 being the best);  118 
(ii) QoL in the past three months (categorical from pretty bad-very well); and  119 
(iii) Change in QoL since the onset of epilepsy (categorical from much decreased-much 120 
increased).  121 
Independent dog-related variables included aspects of the seizure phenotype: seizure 122 
frequency (seizure days), seizure severity and the occurrence of cluster seizures; AED 123 
treatment and the severity of side effects encountered. Carer-related independent variables 124 
included the degree of carer acceptability (rated from strong agreement – strong 125 
disagreement) of seizure frequency and severity, and carer reported QoL change since the 126 
onset of epilepsy (categorical from much decreased-much increased). Kruskal-Wallis and 127 
Mann-Whitney U tests were used to test for associations between outcome measure (i) and 128 
independent variables, and Chi-squared analysis for associations between outcome measures 129 
(ii) and (iii) and independent variables. Where indicated by univariate analyses (p<0.10), 130 
generalised linear mixed model (glmm) analyses were carried out, with breed taken into 131 
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account as a random effect. Multicollinearity was checked for in all models, identified from 132 
inflated standard errors in the models, and thus avoided. Model fit was assessed using the 133 
deviance and Akaike's information criterion. All tests were used two-sided with P<0.050 134 
being considered statistically significant. 135 
 136 
RESULTS 137 
One hundred-and-fifty-nine dogs of 50 breeds met the inclusion criteria. Mean age was 5.8 138 
years (median 5.2 years, range 0.7-12.5 years), with 66 female (52 neutered) and 93 male 139 
dogs (67 neutered). The mean age of onset of seizures was 2.7 years (median 2 years, range 140 
0.3-9.0 years).  141 
 142 
The results of the 36 key questions and the additional 26 questionnaire items are displayed in 143 
Supplementary file A and B respectively. The answers to the seven carer perceived QoL 144 
questions are as follows:   145 
 146 
H1: The seizure phenotype (frequency of seizure days, severity) affects the carer’s perception 147 
of QoL in canine IE patients.  148 
Of the three measures of seizure phenotype (seizure frequency, severity and presence of 149 
cluster seizures), only one measure, seizure frequency, was significantly associated with carer 150 
perceived dog’s QoL, when scored out of ten (Kruskal-Wallis=17.5, p=0.014), when rated for 151 
the past three months categorically (X2=38.8, p=0.003), and when questioned about how it 152 
has changed since the onset of IE (X2=41.2, p=0.016). Higher seizure frequencies were 153 
associated with decreased carer perceived dog’s QoL measures, with the median QoL score 154 
for dogs experiencing less than one seizure day every six months scoring 9 (range 5-10), 155 
41.4% of carers perceived their dog’s QoL as ‘very well: could hardly be better’ and 51.7% 156 
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stating their dog’s QoL had stayed the same since the onset of epilepsy. In contrast, dogs 157 
experiencing ‘more than one seizure day every week’ had a median QoL score of 7.5 (range 158 
4-8), with no carers reporting their dog’s QoL ‘very well: could hardly be better’ and the 159 
majority (87.5%) stating their dog’s QoL had ‘decreased a little’ since the onset of epilepsy. 160 
There were no associations between seizure severity and the presence of cluster seizures with 161 
any measure of QoL (p>0.050). 162 
 163 
H2: There is an effect of being treated with certain AEDs upon carer perception of canine 164 
epilepsy.  165 
There was no difference in carer perceived dog’s QoL scored out of ten or in the past three 166 
months between dogs receiving phenobarbital or not, potassium bromide or not, or diazepam 167 
or not (p>0.050). When QoL was considered since the onset of epilepsy, dogs that received 168 
phenobarbital were rated by their carers to have had a reduction in QoL compared to those 169 
that did not (55.6% vs. 25.7% rated their dog’s QoL to be ‘a little decreased’ since the onset 170 
of epilepsy, respectively; p=0.008), as were dogs that received potassium bromide in 171 
comparison to those that did not (60.5% ‘a little decreased’ vs. 36.8%, respectively; p=0.017). 172 
When the number of AEDs administered was considered, there was a significant difference in 173 
carer perceived dog’s QoL between dogs being treated with third line drugs or not, when 174 
scored out of ten (Mann-Whitney= 1545, p=0.002), rated for the past 3 months categorically 175 
(X2= 10.8 p=0.013), and when questioned about how it has changed since the onset of IE (X2= 176 
13.5, p=0.009), with dogs receiving third line drugs having a reduced QoL compared to those 177 
that do not.  178 
 179 
H3: Side effects of AEDs impact upon carer perception of canine QoL (Table 1)  180 
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The severity of four of the eleven reported AED side effects were significantly associated 181 
with carer perceived dog’s QoL at the univariate level: ‘drinking more’ (Kruskal-Wallis 182 
(KW): 15.5, p=0.008), ‘sleeping more’ (KW: 14.8, p=0.011), ‘wobbly/not coordinated when 183 
walking’ (KW: 16.3, p=0.006) and ‘restlessness/pacing’ (KW: 21.0, p=0.001). Dogs that were 184 
not affected by ‘drinking more’ had a median carer perceived QoL score of 9.0 (range 7.0-185 
10.0), whereas those reported to be very severely affected had a median of 8.0 (range 3.0-186 
10.0). Dogs that were not affected by ‘sleeping more’ had a median carer perceived QoL 187 
score of 9.0 (range 5.0-10.0), whereas those reported to be very severely affected had a 188 
median of 8.0 (range 4.0-10.0). Dogs that were not affected by ‘wobbliness/not coordinated 189 
when walking’ had a median carer perceived QoL score of 9.0 (range 6.0-10.0), whereas 190 
those reported to be very severely affected had a median of 8.0 (range 5.0-10.0). Finally, dogs 191 
that were not affected by ‘restlessness/pacing’ had a median carer perceived QoL score of 9.0 192 
(range 3.0-10.0), whereas those reported to be very severely affected had a median of 8.0 193 
(range 3.0-10.0). These four factors were tested in a generalised linear mixed model (glmm) 194 
with breed taken into account as a random effect. While four factors were significantly 195 
associated with QoL at the univariate level as stated above, only two factors remained 196 
significant when included together in a glmm showing the largest effect on QoL that was not 197 
explained by the other variables. These two factors significantly predicted carer perceived 198 
dog’s QoL: the severity of ‘sleeping more’ and the severity of being ‘wobbly/not coordinated 199 
when walking’ (p<0.050). The less severely the dog was affected by ‘sleeping more’ or being 200 
‘wobbly/not coordinated’, the higher (better) the carer perceived dog’s QoL score. 201 
 202 
H4: The reported severities of AED side effects are associated with the degree of carer 203 
acceptability of AED side effects.  204 
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The severity of seven of the eleven reported AED side effects (rated from 1-5: very mild – 205 
very severe) were significantly associated with carer reported acceptability of side effects 206 
(rated from 1-5: strongly agree – strongly disagree) at the univariate level: ‘eating more’, 207 
‘gaining weight’, ‘drinking more’, ‘urinating more’, ‘sleeping more’, ‘wobbly/not coordinated 208 
when walking’ and ‘restlessness/pacing’ (p<0.050). Increased severity of these side effects 209 
was associated with a decreased level of carer acceptability. There was no association 210 
between the severity of ‘itchiness/skin rash’, ‘vomiting’, ‘diarrhoea’ and ‘coughing’ and 211 
carer-rated acceptability of side effects (p>0.050). 212 
 213 
H5: A dog’s seizure frequency is associated with the degree of carer acceptability of seizure 214 
frequency.   215 
Seizure frequency was significantly associated with the degree of carer acceptability of 216 
seizure frequency (X2=100.5, p<0.001), with carers reporting higher seizure frequencies 217 
disagreeing more that their dogs seizure frequency was acceptable and vice versa. For 218 
example, 46.4% of the carers of dogs experiencing ‘less than one seizure day every six 219 
months’ strongly agreed their dog’s seizure frequency was acceptable, whereas no carers of 220 
dogs experiencing ‘more than one seizure day every week’ strongly agreed their dog’s seizure 221 
frequency was acceptable, with 75.0% strongly disagreeing. 222 
 223 
H6: A dog’s seizure severity is associated with the degree of carer acceptability of seizure 224 
severity.  225 
Seizure severity was significantly associated with the degree of carer acceptability of seizure 226 
severity (X2=100.9, p<0.001), with carers reporting higher seizure severities disagreeing more 227 
that their dog’s seizure severity was acceptable and vice versa. For example, 37.5% of the 228 
carers of dogs experiencing ‘mild’ seizures strongly agreed their dog’s seizure severity was 229 
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acceptable, whereas only 4.8% of carers of dogs experiencing ‘very severe’ seizures strongly 230 
agreed, with 61.9% strongly disagreeing that this severity was acceptable. 231 
 232 
H7: There is an association between changes in carer QoL and carer perception of their 233 
dog’s QoL following the onset of IE.   234 
There was a significant association between the change in carer perceived dog’s QoL after the 235 
onset of IE and the change in the carer’s QoL after the onset of IE (X2=101.7, p<0.001), with 236 
carers reporting their dog’s QoL had decreased more likely to report that their QoL had 237 
decreased too, and vice versa. No carers of dogs whose perceived QoL had ‘much decreased’ 238 
after the onset of epilepsy reported their own QoL was ‘increased’ or ‘much increased’ 239 
(0.0%), with 50.0% stating their QoL was also ‘much decreased’. Participants commented on 240 
suffering to some degree from depression or panic attacks (29.0%) and feeling isolated 241 
(22.0%) as a result of caring for an epileptic dog (Supplementary file B). In contrast, the 242 
majority (71.4%) of carers who perceived their dog’s QoL was ‘much increased’ after the 243 
onset of epilepsy reported their own QoL was also ‘much increased’. 244 
 245 
DISCUSSION 246 
Of the three measures of seizure phenotype (seizure frequency, severity and presence of 247 
cluster seizures), only one measure, seizure frequency (seizure days), was significantly 248 
associated with QoL as perceived by the dog’s carer in this study. Chang and others (2006) 249 
reported that carers of 29 dogs referred to one institution perceived a seizure frequency of 250 
‘one seizure every three to six months’ to be most reasonable for their pet. Most participants 251 
in the current study perceived only a ‘seizure-free’ state acceptable for their pet 252 
(Supplementary file B). Similarly, freedom from seizures is the treatment goal in people (Lee 253 
2014). It was shown that seizure frequency is one of the main risk factor for decreased QoL in 254 
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children with epilepsy (Liu and Han 2015). A significant correlation between seizure severity 255 
and the carer’s perception of their dog’s QoL could not be established. The statistical analysis 256 
did not show whether a history of ‘cluster seizures’ was associated with the dog’s QoL. It 257 
appears that the frequency but not their temporal density was important to carer perceived 258 
QoL of their dog. It would appear reasonable to assume that cluster seizures and status 259 
epilepticus impact on the perceived dog’s QoL, given that the occurrence of cluster seizures 260 
and status epilepticus increased the risk of epilepsy related euthanasia in previous studies 261 
(Saito and others 2001, Monteiro and others 2012, Fredso and others 2014). This might be 262 
related to the fact that the QoL scores are a reflection of the carer’s perception of their dog’s 263 
QoL as a proxy of the dog’s actual QoL.  264 
 265 
The use of two common types of AED (phenobarbital and potassium bromide) had a negative 266 
effect on carer’s perception of their dog’s QoL when considered since the onset of epilepsy, 267 
and there was an effect of the number of AEDs administered, with dogs being treated with 268 
third line drugs experiencing a reduced carer perceived QoL compared to those with 1-2 269 
AEDs. Both, seizure control and number of medications administered, are significantly 270 
associated with QoL in epileptic children (Williams and others 2003). Drug-resistance is 271 
frustrating and challenging to manage. The probability of seizure control is reduced with 272 
successive AED treatment (Lee 2014, Packer and others 2015). Response rates in people with 273 
epilepsy for the first, second or third-line AED as proportion of the population were 47-50%, 274 
10-13% and 2-4% respectively (Kwan and Brodie 2000, Mohanraj and Brodie 2006). 275 
Similarly, in dogs with epilepsy, the response rate as proportion of the population for first, 276 
second and third line AEDs was 37%, 11% and 6% respectively (Packer and others 2015). 277 
There was an association between both seizure frequency and severity and carer-perceived 278 
acceptability of these traits, with higher seizure frequencies and severities perceived to be less 279 
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acceptable by carers. Drug-resistance remains a main cause of epilepsy related euthanasia in 280 
canine IE (Chang and others 2006, Fredso and others 2014, Wessmann and others 2014). 281 
Although freedom from seizures is one of the main goals of epilepsy therapy in people (Lee 282 
2014), it is not easily achieved, and with as few as 14% of treated dogs achieving remission in 283 
hospital dog populations (Packer and others 2014) the management of carer’s expectations by 284 
their veterinarians is vital for understanding the outcomes of therapy. 285 
 286 
The AED side effects that impact on the dog’s QoL and their acceptability by the carer vary 287 
between the 11 investigated side effects. Only the AED side effects ‘sleeping more’ and the 288 
severity of being ‘wobbly/not coordinated when walking’ significantly predicted carer 289 
perception of their dog’s QoL in a multivariate analysis. ‘Drinking more’ and 290 
‘restlessness/pacing’ had further a significant influence on the dog’s QoL at a univariate level. 291 
However, increased severity of these side effects ‘eating more’, ‘gaining weight’, ‘drinking 292 
more’, ‘urinating more’, ‘sleeping more’, ‘wobbly/not coordinated when walking’ and 293 
‘restlessness/pacing’ were associated with a decreased level of carer acceptability. The variety 294 
of the different side effects may explain discrepancies to previous studies. One study reported 295 
that phenobarbital therapy appeared to have minimal side effects on the overall carer 296 
perceived QoL of the studied dog population and thus did not produce a significant problem 297 
for the carers (Lord and Podell 1999), whereas another study reported that acceptable side 298 
effects were one of the greatest concerns for carers (Chang and others 2006). The presence of 299 
side effects is an outcome measure for successful AED therapy in people (Lee 2014). Newer 300 
AEDs commonly fail to show better efficacy than older AEDs. Thus, the selection of the first-301 
line drug is mostly lead by the characteristics and frequency of the AED side effects (Lee 302 
2014). With the advent of newer AEDs in veterinary medicine AED side effects have the 303 
potential to drive drug selection, given the perceived impact of the side effects on the QoL of 304 
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the dog by the carer. Despite multiple AEDs being available in human medicine, there 305 
remains a need for new AEDs in canine and human epilepsy with fewer side effects, increased 306 
efficacy, drugs with different mechanism of action with the potential of synergistic 307 
combination therapy (Lee 2014).  On the other hand, third AED currently used in veterinary 308 
medicine have largely not been through clinical trials in dogs to test their efficacy. Therefore 309 
one could question the necessity of finding even newer if the available ones have not been 310 
tested. 311 
 312 
The change in the carer’s perception of their dog’s QoL was significantly associated with the 313 
change in the carer’s QoL after the onset of IE. Carers reporting a decreased QoL in their 314 
dogs were more likely to report that their QoL had also decreased. This response reflects a 315 
well-known phenomenon in childhood epilepsy, where the disease not only affects the QoL of 316 
the affected child but also of the carer, usually their parent (Cushner-Weinstein and others 317 
2008, Lv and others 2009). The factors correlated with parental QoL were seizure control, 318 
status epilepticus, drug side effects, the degree of the child’s anxiety and depression (Lv and 319 
others 2009). Lack of control over events, unpredictability of events, sleep deprivation and a 320 
feeling of helplessness are known factors in the development of stress in people (Henn and 321 
Vollmayr 2005, Koolhaas and others 2011) and epilepsy influences some, if not all of these 322 
factors. Moreover, up to 50% of mothers are at risk of clinical depression as a consequence 323 
caring for an epileptic child (Ferro and Speechley 2009). Similarly, canine IE can also impact 324 
on the mental health of the carer. A small number of participants commented on suffering to 325 
some degree from depression or panic attacks and feeling isolated as a result of caring for an 326 
epileptic dog (Supplementary file B). Noteworthy is that an improved carer perceived dog’s 327 
QoL resulted also in an improved QoL of the carer demonstrating potentially positive aspects 328 
of IE treatment. This positive finding associated with IE is encouraging and may reflect an 329 
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enhanced connection between diseased pet and carer observed for cats with diabetes mellitus 330 
and their carers (Niessen and others 2010).  331 
 332 
This study showed on a large scale, that canine IE has not only an effect on the perceived QoL 333 
of the affected dog but is also significantly associated with the carer’s perceived QoL. Carers 334 
reporting a decreased QoL in their dogs were more likely to report that their QoL had 335 
decreased too. Seizure frequency, severity of AED side effects sleeping more and ataxia and 336 
dogs receiving third line AEDs were associated with the carer perceived dog’s QoL, with 337 
higher severities predicting lower QoL scores. Thus, optimising seizure control and AED 338 
therapy will not only affect the perceived QoL of the affected dog but also of the carer. The 339 
carer’s QoL affected by caring for an epileptic dog is an important part of IE treatment as the 340 
perceived impact of IE not only on the dogs’ but also on the carers’ QoL is likely to influence 341 
a carer’s choices regarding treatment or euthanasia and requires consideration when treatment 342 
options are discussed.  343 
 344 
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LEGENDS 441 
 442 
Table 1. Impact of antiepileptic drug side effects upon carer perceived dog’s quality of 443 
life score. The factors ‘drinking more’, ‘sleeping more’, ‘wobbly/not coordinated when 444 
walking’ and ‘restlessness/pacing’ were tested in a generalised linear mixed model (glmm) 445 
with breed taken into account as a random effect. The severity of ‘sleeping more’ and the 446 
severity of being ‘wobbly/not coordinated when walking’ (p<0.050) significantly predicted 447 
carer perceived dog’s QoL. The less severely the dog is affected by ‘sleeping more’ or being 448 
‘wobbly/not coordinated when walking’, the higher the carer perceived dog’s QoL score.  449 
 450 
Supplementary file A. Outcome of 7 themes with 36 key questions from a disease-specific 451 
IE online questionnaire as previously published by Wessmann and others (2014).  452 
 453 
Supplementary file B. Outcome of 26 complementary questionnaire items as previously 454 
published by Wessmann and others (2014). 455 
 456 
 457 
458 
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Table 1. Impact of antiepileptic drug side effects upon carer perceived dog’s quality of 459 
life score. The factors ‘drinking more’, ‘sleeping more’, ‘wobbly/not coordinated when 460 
walking’ and ‘restlessness/pacing’ were tested in a generalised linear mixed model (glmm) 461 
with breed taken into account as a random effect. The severity of ‘sleeping more’ and the 462 
severity of being ‘wobbly/not coordinated when walking’ (p<0.050) significantly predicted 463 
carer perceived dog’s QoL. The less severely the dog is affected by ‘sleeping more’ or being 464 
‘wobbly/not coordinated when walking’, the higher the carer perceived dog’s QoL score. 465 
 466 
Risk factor Sub-category Coefficient (95% 
CI) 
SE t P value 
Intercept - 5.7 (4.5-6.9) 0.6 9.2 0.000 
Sleeping more Side effect not present 1.7 (0.4-2.9) 0.6 2.6 0.010 
Very mild 1.3 (-0.1-2.6) 0.7 1.8 0.072 
Mild 1.5 (0.2=2.9) 0.7 2.2 0.030 
Moderate 1.0 (-0.3-2.3) 0.6 1.96 0.114 
Severe 1.4 (-0.1-2.8) 0.8 1.8 0.702 
Very severe Reference 
Wobbly/not 
coordinated 
when walking 
Side effect not present 1.4 (0.4-2.4) 0.5 2.8 0.006 
Very mild 1.1 (-0.0-2.1) 0.5 2.0 0.053 
Mild 0.7 (-0.5-1.8) 0.6 1.1 0.258 
Moderate 0.3 (-0.8-1.4) 0.6 0.6 0.553 
Severe 0.9 (-0.3-2.1) 0.6 1.5 0.138 
Very severe Reference 
CI, confidence interval; SE, standard error  467 
 468 
